OR WAIT null SECS
March 21, 2022
Moderna has reached an agreement with the Ministry of Health, Labor, and Welfare of Japan (MHLW) to supply Japan with an additional 70 million doses of its COVID-19 Booster Vaccine.
March 18, 2022
Emmes has acquired Casimir, marking its fourth major acquisition.
March 17, 2022
Catalent has announced the completion of a $30 million project at its facility in Limoges, France focused on biopharmaceutical development and drug product manufacturing.
March 16, 2022
Spectrum Chemical is adding twelve products to its bioCERTIFIED product line.
ProteoGenix’s new XtenCHO Transient Expression can achieve up to ten times higher yields than market-leading CHO systems.
CDMO Almac Pharma Services expanded its European ultra-low temperature packaging capabilities.
March 14, 2022
Evitria has entered into an agreement with mAbsolve that will allow the company to use mAbsolve’s gene silencing technology in their antibody cells.
March 10, 2022
Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.
March 09, 2022
Spectrum Chemical has further expanded its bioCERTIFIED product portfolio to support the growing global demand for new vaccines and therapeutics.
March 08, 2022
Johnson & Johnson have announced a landmark agreement to enable the manufacturing and availability of its COVID-19 vaccine in Africa by an African company.